Digoxin-quinidine interaction in patients with chronic renal failure.
- 1 December 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 66 (6) , 1277-1280
- https://doi.org/10.1161/01.cir.66.6.1277
Abstract
We evaluated the effect of quinidine on digoxin pharmacokinetic in six patients with severe renal failure. Quinidine reduced the total body clearance of digoxin from 1.87 to 1.06 l/hour (p less than 0.001), and prolonged the digoxin half-life of elimination from 5.20 to 9.61 days (p less than 0.01). The digoxin volume of distribution was unchanged. Renal clearance of digoxin was negligible; thus, the decrease in total body clearance was due to a decrease in the nonrenal clearance of digoxin. The mean trough serum concentrations of quinidine ranged from 1.0 to 3.0 micrograms/ml. We conclude that in patients with chronic renal failure, the dose of digoxin should be decreased by 50% if quinidine therapy is initiated.This publication has 15 references indexed in Scilit:
- Quinidine-digoxin interaction: Time course and pharmacokineticsThe American Journal of Cardiology, 1981
- Effect of quinidine on the digoxin receptor in vitro.Journal of Clinical Investigation, 1981
- Effect of Quinidine on Digoxin Concentration in Skeletal Muscle and Serum in Patients with Atrial FibrillationNew England Journal of Medicine, 1981
- Digoxin-quinidine interaction in patients with renal failureJournal of Molecular Medicine, 1981
- Pharmacokinetics of digoxin in patients subjected to the quinidine- digoxin interaction.Published by Wiley ,1981
- Quinidine decreases both renal and metabolic clearance of digoxinThe American Journal of Cardiology, 1980
- Noncompartmental Determination of the Steady‐State Volume of DistributionJournal of Pharmaceutical Sciences, 1979
- Digoxin-Quinidine InteractionNew England Journal of Medicine, 1979
- Effect of quinidine on plasma concentrations of digoxin.BMJ, 1978